Table: Kissei Pharm -2025/26 group results

Kissei Pharmaceutical

11/05/2026 08:30

May 11 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           97.41           88.33          95.70        48.00    
               (+10.3 pct)     (+16.9 pct)    (-1.8 pct)    (+4.7 pct) 
  Operating     loss 2.93          5.77           4.40         1.90    
                               (+43.7 pct)                             
  Recurring     loss 1.16          6.97           6.00         2.80    
                               (+13.5 pct)                             
  Net
  Net             13.78           11.96          14.50         8.00    
               (+15.2 pct)     (+7.2 pct)     (+5.2 pct)    (+2.8 pct) 
  EPS          331.54 yen      274.21 yen     356.65 yen    196.77 yen 
  Ann Div      160.00 yen      100.00 yen     170.00 yen               
  -Q2 Div       60.00 yen       45.00 yen     105.00 yen               
  -Q4 Div      100.00 yen       55.00 yen      65.00 yen               
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T